Results from a new study, presented at the 33rd Annual Meeting of The European Bone & Joint Infection Society, showed complete wound healing in patients with chronic osteomyelitis treated with ...

BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today the launch of a new ...

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery, today announced that ...

BONESUPPORT AB, an emerging leader in innovative injectable bioresorbable bone graft substitute products to treat bone voids caused by trauma, infection, disease or related surgery, today announced ...

Cerament G provides an initial high concentration of gentamicin at the fracture site, followed by sustained release over at least 28 days, as the product promotes bone remodeling. The 230-patient ...

Rigshospitalet to evaluate CERAMENT' platform for use in bone tumors LUND, Sweden, Jan. 7, 2016 /PRNewswire/ --BONESUPPORT', an emerging leader in injectable bone substitutes for orthopedic trauma, ...

Swedish startup BoneSupport has raised $14 million to back the drug-eluting aspects of its synthetic bone substitute. Its injectable, antibiotic-eluting product Cerament G was CE marked in 2013 and is ...

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery, today announced that the ...

* NEW PRECLINICAL DATA(1) HAS BEEN PUBLISHED THAT FURTHER SUPPORT BONESUPPORT'S AMBITION TO DEVELOP A COMBINATION PRODUCT OF COMPANY'S PLATFORM TECHNOLOGY CERAMENT® AND BISPHOSPHONATE, A ...

Swedish startup BoneSupport raised $37 million in a round of equity and debt financing it says it will use to support its Cerament platform, which is a drug-eluting, synthetic bone substitute. The ...